Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties

scientific article published on 01 December 1993

Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/17453679308994587
P698PubMed publication ID8291408

P2093author name stringJ Keller
S A Schmidt
O Kristensen
P Kjaersgaard-Andersen
U Lucht
A Nafei
G Teichert
P433issue6
P304page(s)639-642
P577publication date1993-12-01
P1433published inActa OrthopaedicaQ10400516
P1476titleIndomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties
P478volume64

Reverse relations

cites work (P2860)
Q33942168A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery
Q40766760Biochemical responses in cultured cells following exposure to (89)SrCl(2): potential relevance to the mechanism of action in pain palliation
Q44242456COX-2 selective NSAID decreases bone ingrowth in vivo
Q35581260Cox-2 Selective Inhibitors and Bone
Q35668938Do Nonsteroidal Anti-Inflammatory Drugs Cause Endoprosthetic Loosening? Mid- to Long-Term Follow-Up of 100 Total Hip Arthroplasties after Local NSAID Infiltration
Q64107138Heterotopic Ossification: A Challenging Complication of Total Hip Arthroplasty: Risk Factors, Diagnosis, Prophylaxis, and Treatment
Q39485664Heterotopic bone formation about the hip undergoes endochondral ossification: a rabbit model
Q47698255Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty
Q34702475Neurogenic heterotopic ossification in spinal cord injury.
Q24799015Nodular osteochondrogenic activity in soft tissue surrounding osteoma in neurogenic para osteo-arthropathy: morphological and immunohistochemical study
Q24200252Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty
Q24246587Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty
Q33978320Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty
Q28088671Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis
Q24235518Pharmacological interventions for treating acute heterotopic ossification
Q24245975Pharmacological interventions for treating acute heterotopic ossification
Q34137773Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease
Q35215473Prevention of heterotopic ossification after total hip replacement with NSAIDs
Q46743614Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty
Q33722361Surgical Excision of Heterotopic Ossification Leads to Re-Emergence of Mesenchymal Stem Cell Populations Responsible for Recurrence
Q70913946The effect of low dose diclofenac sodium administered locally on heterotopic bone formation in rats
Q24673561Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach

Search more.